Verve Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Market Capitalization	160	224	482	323	128	12	Upgrade
Market Cap Growth	-52.26%	-53.65%	49.30%	152.96%	966.78%	-50.56%	Upgrade
Enterprise Value	102	129	346	308	123	10	Upgrade
Last Close Price	0.06	0.09	0.19	0.15	0.07	0.01	Upgrade
PE Ratio	93.20	130.96	1136.02	-	-	-	Upgrade
PS Ratio	2136.25	414152.53	1892107.55	-	15969.05	-	Upgrade
PB Ratio	0.94	1.33	2.90	3.36	3.63	0.66	Upgrade
P/TBV Ratio	0.94	1.33	2.90	3.36	3.63	0.66	Upgrade
P/OCF Ratio	49.86	82.63	1463.96	-	-	-	Upgrade
EV/Sales Ratio	-	238817.54	1355681.78	-	15399.14	-	Upgrade
Debt / Equity Ratio	0.00	0.00	-	-	-	-	Upgrade
Quick Ratio	17.52	37.11	33.13	62.53	16.67	6.21	Upgrade
Current Ratio	32.30	50.60	47.69	62.55	16.74	6.25	Upgrade
Return on Equity (ROE)	1.05%	1.02%	0.32%	-2.28%	-3.29%	-6.04%	Upgrade
Return on Assets (ROA)	-1.23%	-1.21%	-1.19%	-1.41%	-2.01%	-4.08%	Upgrade
Return on Capital (ROIC)	-1.25%	-1.23%	-1.21%	-1.43%	-2.06%	-4.19%	Upgrade
Earnings Yield	1.10%	0.76%	0.09%	-0.46%	-0.69%	-8.96%	Upgrade
FCF Yield	-10.89%	-8.56%	-2.87%	-1.72%	-1.97%	-23.54%	Upgrade
Buyback Yield / Dilution	-1.95%	-7.48%	-22.71%	-19.46%	-30.18%	-15.32%	Upgrade

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.